From early warning signs to prevention tips, here’s all that you need to know about this rare hormonal disorder.
Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...
Cushing syndrome occurs due to abnormally high levels of cortisol, which is commonly related to steroid use. Symptoms include weight gain, thinning skin, fluid retention, and stretch marks ...
Cushing syndrome is caused by long-term exposure to high cortisol levels. Diagnosing the cause can help determine the type of treatment needed. Lifestyle changes can also help with symptoms.
Hallmark symptoms of Cushing disease, including abdominal striae and facial rounding, were more common among younger patients than older patients.
Older age was tied to a higher prevalence of 10 comorbidities among a group of 608 people with Cushing’s disease. Younger age was associated with most hallmark features of Cushing’s disease.
It’s spring! The weather is warming and the trails are calling, but you’ve got the “pudgy pony blues.” ...
8d
Zacks.com on MSNCorcept Shares Rise More Than 55% in 6 Months: Here's WhyCORT's Cushing's syndrome drug, Korlym, is driving revenues. The FDA's acceptance of the NDA for relacorilant also bodes well ...
Corcept is studying relacorilant in a variety of serious disorders in addition to endogenous hypercortisolism (Cushing’s ...
Australians suffering from the debilitating condition Cushing’s Disease have scored a huge win after a vital medication was added to the Pharmaceutical Benefits Scheme.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for relacorilant to treat patients with Cushing syndrome (hypercortisolism).
Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results